Market Closed - Nasdaq Stockholm 11:29:55 2024-04-25 am EDT 5-day change 1st Jan Change
192 SEK +0.79% Intraday chart for Stille AB +6.96% +27.15%
Sales 2024 * 520M 47.77M Sales 2025 * 601M 55.21M Capitalization 1.71B 157M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.29 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.85 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 106
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.79%
1 week+6.96%
Current month+6.67%
1 month+11.30%
3 months+28.00%
6 months+103.82%
Current year+27.15%
More quotes
1 week
179.00
Extreme 179
204.00
1 month
173.00
Extreme 173
204.00
Current year
142.50
Extreme 142.5
204.00
1 year
94.20
Extreme 94.2
204.00
3 years
94.20
Extreme 94.2
204.00
5 years
70.00
Extreme 70
204.00
10 years
8.45
Extreme 8.45
204.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 23-03-19
Director of Finance/CFO 50 20-05-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 99-12-31
Director/Board Member 61 20-12-31
Chairman 52 19-12-31
More insiders
Date Price Change Volume
24-04-25 192 +0.79% 24 343
24-04-24 190.5 +3.53% 12,160
24-04-23 184 +0.82% 13,699
24-04-22 182.5 +1.11% 1,544
24-04-19 180.5 +0.56% 1,601

Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT

More quotes
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
More about the company

Quarterly revenue - Rate of surprise